C12N 2710/16271
Demonstrated in vivo effect
C12N2710/16271 (Demonstrated in vivo effect) appears on 14 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 23
- Assignees
- 22
- Inventors
- 33
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 4 |
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 4 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 3 |
| 2022 | 1 | 1 |
| 2023 | 2 | 2 |
| 2024 | 1 | 3 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Epstein-BARR virus nucleic acid constructs and vaccines made therefrom, and methods of using same3 Mar 2026US 12,564,628 B2The Wistar Institute of Anatomy and Biology
- Epstein-Barr Virus antigen constructs1 Apr 2025US 12,264,179 B2Glaxosmithkline Biologicals SA
- Epstein-barr virus vaccines11 Jun 2024US 12,005,115 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Epstein-barr virus antigen constructs3 Oct 2023US 11,773,139 B2Glaxosmithkline Biologicals SA
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response7 Feb 2023US 11,572,389 B2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Epstein-barr virus vaccines12 Dec 2024US 2024/0408195 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Vaccine compositions of herpesvirus envelope protein combinations to induce immune response15 Aug 2024US 2024/0270796 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Epstein-barr virus antigen constructs7 Mar 2024US 2024/0076318 A1Glaxosmithkline Biologicals SA
- Ebv-targeted allogeneic b cell vaccine and preparation method therefor21 Dec 2023US 2023/0405111 A1West China Hospital, Sichuan University
- Methods to alter latency in ebv+ malignancies23 Feb 2023US 2023/0053688 A1Cornell University
Most cited
By later US patents
- Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease6US 10,314,906 B2University of Massachusetts · 2019
- Virus-like particle compositions and vaccines against epstein-barr virus infection and disease3US 10,960,072 B2University of Massachusetts · 2021
- Epstein-Barr-virus vaccine2US 10,300,129 B2Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmb) · 2019
- Epstein-Barr virus vaccines1US 10,744,199 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2020